Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.28 EUR
277.78 M EUR
1.57 B EUR
135.79 M
About Livzon Pharmaceutical Group, Inc. Class A
Sector
Industry
Website
Headquarters
Zhuhai
Founded
1992
ISIN
CNE100001QV5
FIGI
BBG005Y0JDG4
Livzon Pharmaceutical Group, Inc. engages in the research and development, production, and distribution of pharmaceutical products. It offers drug preparation products, bulk medicines and intermediates, and diagnostic reagents and equipment. The company was founded on March 1, 1992, and is headquartered in Zhuhai, China.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Livzon Pharmaceutical Group Inc Class H stocks are traded under the ticker LP6.
We've gathered analysts' opinions on Livzon Pharmaceutical Group Inc Class H future price: according to them, LP6 price has a max estimate of 5.29 EUR and a min estimate of 2.87 EUR. Watch LP6 chart and read a more detailed Livzon Pharmaceutical Group Inc Class H stock forecast: see what analysts think of Livzon Pharmaceutical Group Inc Class H and suggest that you do with its stocks.
Yes, you can track Livzon Pharmaceutical Group Inc Class H financials in yearly and quarterly reports right on TradingView.
Livzon Pharmaceutical Group Inc Class H is going to release the next earnings report on Oct 28, 2025. Keep track of upcoming events with our Earnings Calendar.
LP6 earnings for the last quarter are 0.08 EUR per share, whereas the estimation was 0.07 EUR resulting in a 21.05% surprise. The estimated earnings for the next quarter are 0.07 EUR per share. See more details about Livzon Pharmaceutical Group Inc Class H earnings.
Livzon Pharmaceutical Group Inc Class H revenue for the last quarter amounts to 366.22 M EUR, despite the estimated figure of 371.34 M EUR. In the next quarter, revenue is expected to reach 339.11 M EUR.
LP6 net income for the last quarter is 75.17 M EUR, while the quarter before that showed 80.85 M EUR of net income which accounts for −7.03% change. Track more Livzon Pharmaceutical Group Inc Class H financial stats to get the full picture.
Yes, LP6 dividends are paid annually. The last dividend per share was 0.13 EUR. As of today, Dividend Yield (TTM)% is 3.52%. Tracking Livzon Pharmaceutical Group Inc Class H dividends might help you take more informed decisions.
Livzon Pharmaceutical Group Inc Class H dividend yield was 4.35% in 2024, and payout ratio reached 49.37%. The year before the numbers were 6.14% and 63.78% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 26, 2025, the company has 9.07 K employees. See our rating of the largest employees — is Livzon Pharmaceutical Group Inc Class H on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Livzon Pharmaceutical Group Inc Class H EBITDA is 372.74 M EUR, and current EBITDA margin is 27.22%. See more stats in Livzon Pharmaceutical Group Inc Class H financial statements.
Like other stocks, LP6 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Livzon Pharmaceutical Group Inc Class H stock right from TradingView charts — choose your broker and connect to your account.